HAVAH Therapeutics is focused on developing better hormonal therapies to help millions of women lead longer, better lives.
HAVAH Therapeutics has raised $507K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2024.
HAVAH Therapeutics is headquartered in Palo Alto, United States.
HAVAH Therapeutics is focused on developing better hormonal therapies to help millions of women lead longer, better lives.
HAVAH Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"HAVAH Therapeutics — Funding & Investors." VCBacked, May 30, 2024, https://www.vcbacked.co/company/havah-therapeutics. Accessed September 29, 2026.
VCBacked. (2024). HAVAH Therapeutics — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/havah-therapeutics
{{cite web |title=HAVAH Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/havah-therapeutics |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated